ACOM Labs, Inc.

The goal of this clinical trial is to test the safety of intralesional injections of triamcinolone self-administered into acne lesions via an injection assistance device. The main question[s] it aims to answer are:
* is use of the injection assistance device safe?
* is delivery of triamcinolone to acne lesions via the injection assistance device efficacious?
Participants will self-inject low dose triamcinolone into acne lesions and track lesion response via photos and survey for 14 days following injection.